These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9772016)

  • 1. Relationship of disease severity to decline on specific cognitive and functional measures in Alzheimer disease.
    Schmeidler J; Mohs RC; Aryan M
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):146-51. PubMed ID: 9772016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value and functional correlations of the ADAS-Cog scale in Alzheimer's disease: data on NORMACODEM project].
    Monllau A; Pena-Casanova J; Blesa R; Aguilar M; Bohm P; Sol JM; Hernandez G
    Neurologia; 2007 Oct; 22(8):493-501. PubMed ID: 17602338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional decline in Alzheimer's disease: a longitudinal study.
    Green CR; Mohs RC; Schmeidler J; Aryan M; Davis KL
    J Am Geriatr Soc; 1993 Jun; 41(6):654-61. PubMed ID: 8505464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The characteristics of patients with uncertain/mild cognitive impairment on the Alzheimer disease assessment scale-cognitive subscale.
    Pyo G; Elble RJ; Ala T; Markwell SJ
    Alzheimer Dis Assoc Disord; 2006; 20(1):16-22. PubMed ID: 16493231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Item analysis of ADAS-Cog: effect of baseline cognitive impairment in a clinical AD trial.
    Sevigny JJ; Peng Y; Liu L; Lines CR
    Am J Alzheimers Dis Other Demen; 2010 Mar; 25(2):119-24. PubMed ID: 19949163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive Performance Test: a new approach to functional assessment in Alzheimer's disease.
    Burns T; Mortimer JA; Merchak P
    J Geriatr Psychiatry Neurol; 1994; 7(1):46-54. PubMed ID: 8192830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease Assessment Scale: reliability and validity in a multicenter clinical trial.
    Weyer G; Erzigkeit H; Kanowski S; Ihl R; Hadler D
    Int Psychogeriatr; 1997 Jun; 9(2):123-38. PubMed ID: 9309486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the reliability of ADAS-Cog change scores.
    Grochowalski JH; Liu Y; Siedlecki KL
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2016 Sep; 23(5):513-29. PubMed ID: 26708116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes.
    Ascher-Svanum H; Chen YF; Hake A; Kahle-Wrobleski K; Schuster D; Kendall D; Heine RJ
    Clin Ther; 2015 Jun; 37(6):1195-205. PubMed ID: 25676448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.
    Karin A; Hannesdottir K; Jaeger J; Annas P; Segerdahl M; Karlsson P; Sjögren N; von Rosen T; Miller F
    Acta Neurol Scand; 2014 Feb; 129(2):114-22. PubMed ID: 23763450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild cognitive impairment.
    Schneider LS
    Am J Geriatr Psychiatry; 2005 Aug; 13(8):629-32. PubMed ID: 16085778
    [No Abstract]   [Full Text] [Related]  

  • 13. Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease.
    Ihl R; Ferris S; Robert P; Winblad B; Gauthier S; Tennigkeit F
    Int J Geriatr Psychiatry; 2012 Jan; 27(1):15-21. PubMed ID: 21384431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer Disease Assessment Scale: a subtest analysis.
    Zec RF; Landreth ES; Vicari SK; Belman J; Feldman E; Andrise A; Robbs R; Becker R; Kumar V
    Alzheimer Dis Assoc Disord; 1992; 6(3):164-81. PubMed ID: 1485931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials.
    Galasko D; Bennett DA; Sano M; Marson D; Kaye J; Edland SD;
    Alzheimer Dis Assoc Disord; 2006; 20(4 Suppl 3):S152-69. PubMed ID: 17135809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of dementia rating scales in Parkinson's disease dementia.
    Harvey PD; Ferris SH; Cummings JL; Wesnes KA; Hsu C; Lane RM; Tekin S
    Am J Alzheimers Dis Other Demen; 2010 Mar; 25(2):142-8. PubMed ID: 19359706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients.
    Ferris S; Ihl R; Robert P; Winblad B; Gatz G; Tennigkeit F; Gauthier S
    Alzheimers Dement; 2009 Sep; 5(5):375-9. PubMed ID: 19751916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease.
    Helmer C; Andrieu S; Pérès K; Orgogozo JM; Vellas B; Dartigues JF;
    Dement Geriatr Cogn Disord; 2007; 23(3):168-74. PubMed ID: 17215578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.
    Stern RG; Mohs RC; Davidson M; Schmeidler J; Silverman J; Kramer-Ginsberg E; Searcey T; Bierer L; Davis KL
    Am J Psychiatry; 1994 Mar; 151(3):390-6. PubMed ID: 8109647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empirical scaling of the stages of cognitive decline in senile dementia.
    Overall JE; Scott J; Rhoades HM; Lesser J
    J Geriatr Psychiatry Neurol; 1990; 3(4):212-20. PubMed ID: 2073309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.